The largest database of trusted experimental protocols

11 protocols using mouse igg1κ

1

HLA Expression on Human Spermatozoa

Check if the same lab product or an alternative is used in the 5 most similar protocols
The presence of HLA class I and II on the surface of spermatozoa was assessed by direct immunofluorescence using a BD FACSCalibur (BD Biosciences, USA) flow cytometer. Two tubes for each sample containing 1 × 106 spermatozoa were prepared. One was incubated with phycoerythrin (PE) mouse anti‐human HLA‐ABC (clone: G46‐2.6, BD pharmingen, USA) and the other was incubated with phycoerythrin (PE) mouse anti‐human HLA‐DR (clone: G46‐6, BD pharmingen, USA) at room temperature for 30 min. After two washes with AllGrad Wash (400 g for 5 min), tubes were run through the flow cytometer. Data from at least 100,000 events were collected using forward scatter (a logarithmic amplifier) and side angle of light scatter (a logarithmic amplifier). As a negative control, we used unstained control. Isotype controls [Mouse IgG1, κ (clone: G46‐2.6, BD pharmingen, USA) and Mouse IgG2a, κ (clone: G46‐6, BD pharmingen, USA)] were used to determine background fluorescence (autofluorescence and non‐specific binding of antibodies). To remove background fluorescence, antibody titration was done and the optimal titer that showed minimum background was selected. Noteworthy, cell viability test was not performed because we removed abnormal and dead spermatozoa by AllGrad solution before staining. Fluorescence data were obtained with the logarithmic amplifier. We used flowJo vx software for data analyses.
+ Open protocol
+ Expand
2

Immunophenotyping of Neural Progenitors

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cells were singularized with Accutase and fixed using cold 90% methanol. Primary antibodies against nestin (Santa Cruz Biotech SC23927), β-3 tubulin (Sigma T2200), and an isotype control (Mouse IgG1, κ; BD 550878) were used at a 1:500 dilution in 0.3% BSA and incubated overnight at 4°C. Secondary antibodies (AlexaFluor 488 and 568-conjugated) were used at 1:500 in 0.3% BSA and incubated for 1 hr at room temperature. Samples were analyzed on a BD Canto flow cytometer using BD FACSDiva software.
+ Open protocol
+ Expand
3

Characterizing Melanoma Heterogeneity

Check if the same lab product or an alternative is used in the 5 most similar protocols
Primary tumors, lymph nodes, and lungs were enzymatically digested into single-cell suspensions to characterize melanoma heterogeneity as described above. Erythrocytes were lysed with 1 × ACK buffer (1.5 M NH4Cl, 100 mM NaHCO3, 10 mM EDTA) and washed with PBS. Cells from primary tumors, lymph nodes, lungs, and blood were stained for viability using the LIVE/DEAD™ Fixable Aqua Dead Cell Stain Kit (L34957, Invitrogen™, Carlsbad, CA) for 20 min at 4 °C. After washing with PBS, the cells were stained with a cocktail of primary antibodies or corresponding isotype controls, including EpCAM (2221100, SONY, Tokyo, Japan), Trop2 (1B-898-C100, Exbio, Vestec, Czech Republic), and CD271 (562122, BD Biosciences, San Jose, CA) (Supplementary Tables 1 and 2), as well as mouse IgG2b (400342, Biolegend, San Diego, CA), and mouse IgG1 κ (557872, BD Biosciences, San Jose, CA). After 20 min of incubation at 4 °C, staining with Streptavidin PE (12-4317, eBioscience, San Diego, CA) was performed for 20 min at 4 °C. The gating of positive populations was done using isotype controls. Only viable single GFP+ cells without debris were included in the analysis. The samples were measured on an Attune Classic flow cytometer (ThermoFisher Scientific, Waltham, MA) and analyzed using FlowJo software.
+ Open protocol
+ Expand
4

Evaluating Cell Surface Antigen Expression

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cell surface antigen expressions were analyzed using flowcytometry. The cells were incubated with anti-HER2-PE (clone; #191924, isotype; mouse IgG2b, R&D Systems, MN), anti-NKG2D-APC (clone; 1D11, isotype; mouse IgG1κ, BD Biosciences, Heidelberg, Germany), anti-Tim3-APC (clone; #344823, isotype; rat IgG2a, R&D systems) for 30 min at 4 °C. The cells were then washed and analyzed using an EC800 flowcytometer (SONY, Tokyo, Japan).
+ Open protocol
+ Expand
5

Immunophenotyping of Human Endothelial Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
HUVECs were grown in 12-well plates as described above. Thereafter, supernatant was aspired; the cells were washed with warm sterile PBS and de-attached with TrypLE. The reaction was stopped with complete EGM medium, the cells aspired and transferred into FACS tubes and centrifuged at 1200 rpm for 7 minutes at RT. Then, the cells were then incubated with Fc-blocking solution (anti-CD16/anti-CD32) (eBioscience, Cat. No. 14-0161-81C) for 10 minutes at +4°C. Thereafter, rabbit-anti-human HSP60 (Santa Cruz Biotechnologies, Cat. No. sc-13966, clone H-300) at 1:25 dilution together with a monoclonal mouse-anti-human CD31 FITC antibody (BD, Cat. No. 555445) at 1:20 dilution in 2%FCS/PBS was added and cells incubated for 30 minutes at +4°C. After washing with 2%FCS/PBS, the secondary donkey-anti-rabbit A568 (Abcam, Cat. No. ab175470) was added at 1:200 dilution, and incubated for 30 minutes at +4°C. After a final washing step, the cells were re-suspended in 2%FCS/PBS and acquired on a FACS Verse (BD Biosciences). The results were analyzed using FlowJo. As a negative control, secondary alone or mouse IgG1κ (BD, Cat. No. 51-35405X) were used.
+ Open protocol
+ Expand
6

Investigating Anti-C2 mAb Mechanism

Check if the same lab product or an alternative is used in the 5 most similar protocols

Example 9

To investigate the mechanism of inhibition of the anti-C2 mAbs, glycosylated recombinant human C2 was pre-incubated with mAbs anti-C2-5F2.4, anti-C2-13, anti-C2-32, anti-C2-35 and anti-C2-60 (at a molar C2-to-antibody ratio of 1:2) for 30 min at RT. In parallel, isotype controls of mouse IgG1κ and IgG2aκ (both from BD Biosciences) were tested as negative controls. Then, human C1s (C1s-to-C2 ratio of 1:25; Calbiochem) was added for 1 hour at 37° C. The mixtures were analyzed by SDS-PAGE using the pre-cast gel NuPage® Novex® system (Invitrogen), and stained with Coomassie brilliant blue.

As shown in FIG. 12, none of the anti-C2 mAbs inhibited the cleavage of recombinant C2 by C1s. Moreover, no effect on the cleavage of C2 by C1s was observed (data not shown) when higher concentrations (at molar C2-to-antibody ratios from ≈1:3 to ≈1:7) of anti-C2 mAbs were used. Collectively, these results demonstrated that mAbs anti-C2-5F2.4, anti-C2-13, anti-C2-32, anti-C2-35 and anti-C2-60 did not recognize an epitope on or near the C1s cleavage site (i.e., Arg243−|−Lys244 bond; http://www.uniprot.org/uniprot/P09871).

+ Open protocol
+ Expand
7

Psoriasin Inhibits Bacterial Growth

Check if the same lab product or an alternative is used in the 5 most similar protocols
Human uroepithelial cells, TERT-NHUC were treated with 6 or 30 mM glucose. After 24 h of treatment, medium was removed, and cells were lysed in 1% Triton X‐100 in PBS. Cell free supernatant was obtained by centrifugation at 8000 g for 5 mins and then incubated for 30 mins at 37 °C with 1 µg/ml of monoclonal mouse anti‐psoriasin antibody (Santacruz Biotechnology) or the same concentration of an isotype control antibody (mouse (Ig)G1,κ; BD Biosciences). Bacteria were prepared as above and 50 µl from 104 CFU/ml bacterial suspension was added to 150 µl of pretreated cell lysate. After incubation for 30 min at 37 °C, 100 µl aliquots were plated and bacterial survival was determined by viable count. Results were expressed in relation to control cell lysates pretreated with control antibodies.
Urine samples, with no bacterial growth from nondiabetic controls and T2D patients were collected, and E. coli CFT073 was prepared as above and 50 µl from 104 CFU/ml bacterial suspension was added to 150 µl of urine with 5 µM of psoriasin peptide. After incubation for 30 min at 37 °C, 100 µl aliquots were plated and bacterial survival was determined by viable count.
+ Open protocol
+ Expand
8

Monocyte-Macrophage Differentiation Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
The activity of THP-1 monocytic cells (their differentiation into macrophages without PMA but only in the presence of the studied plates) was checked by expression of CD 14 and CD 68 antibodies. The expression of CD14 and CD68 were evaluated by flow cytometry using mouse anti-human CD14 FITC and mouse anti-human CD64 Alexa Fluor 647 clone Y1:82A antibody (BD Pharmingen, San Diego, CA, USA). Cells were compared to an isotype control, mouse IgG1 κ and mouse IgG2b κ (BD Pharmingen). Briefly, the cells were stained in phosphate-buffered saline (PBS, Ca2+- and Mg2+-free) supplemented with 2% bovine calf serum (BCS, Hyclone, Logan, UT, USA). After the final wash, cells were re-suspended in PBS and analyzed by FACS using the Navios flow cytometer (Beckman Coulter, Brea, CA, USA).
+ Open protocol
+ Expand
9

Characterization of MSC Phenotype

Check if the same lab product or an alternative is used in the 5 most similar protocols
The third-passage cells were harvested and washed 3 times with PBS. Then, a single-cell suspension was obtained by digestion with 0.25% trypsin. The cells were resuspended with PBS-1% fetal bovine serum (FBS) after centrifugation. Next, 1×106 cells were incubated in the dark for 30 min at 4°C with the corresponding commercial monoclonal antibodies (CD29, cloneTS2/16, BioLegend, Ref.303003, 1: 20; CD90, clone5E10, BD Pharmingen™, Ref.555596, 1: 20; CD166, clone3A6, Ancell Corporation, Ref.393–040, 1: 50; CD45, cloneHI30, BD Pharmingen™, Ref.555483, 1: 5; CD34, clone581, BD Pharmingen™, Ref.555822, 1: 5; Isotype controls: Mouse IgG1, AbD Serotec, Ref.MCA928F, 1: 10; Mouse IgG1, κ, BD Pharmingen™, Ref.555749, 1: 5). Flow cytometry was performed on a FACSCanto device (BD Biosciences). The data were analyzed using FACSDiva (BD Biosciences) and FlowJo software (TreeStar, Inc, Ashland, OR).
+ Open protocol
+ Expand
10

OVA-H-2Kb Presentation and T Cell Activation

Check if the same lab product or an alternative is used in the 5 most similar protocols
To investigate OVA-H-2Kb production, BM-DCs were incubated for 24 h with PBS, OVA, or rlipo-OVA and stained with CD16/CD32 (clone 2.4G2, BD Biosciences) prior to cell surface staining with the CD11c-FITC (clone N418, Biolegend, San Diego, CA, USA) and SII/H-2Kb-PE (clone 25-D1.16, eBioscience) antibodies and the isotype control antibody (mouse IgG1κ, BD Biosciences). Then, the cells were subjected to intracellular SII/H-2Kb or isotype control antibody staining using the Intracellular Fixation & Permeabilization Buffer Set according to the manufacturer's instructions (eBioscience). To confirm the presentation of SII/H-2Kb could activate T cells, BM-DCs (1 × 104) were cultured with 1 × 105 OT-I cells (purity > 90%) which were purified by CD8a+ T cell isolation kit (Miltenyi Biotec, Auburn, CA, USA), 1 μCi/well [3H]thymidine (Perkin-Elmer Life Science, Boston, MA) was added at 54 h, [3H]thymidine incorporation was measured at 72 h of culture, and performing scintillation counting. The level of IFN-γ was determined using ELISA kits (eBioscience) on day 5.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!